Marty Makary, President Trump’s pick to be FDA commissioner, promised to step down as an adviser to various health tech, medical device, and telehealth startups if confirmed.
That's the opposite approach of Makary, whose sweeping rhetoric and biting criticism often veer into hyperbole, according to a review of recent speeches, interviews, and podcast a
1don MSN
Dr. Marty Makary rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV. Now the Johns Hopkins University surgeon and researcher has been nominated to lead the Food and Drug Administration.
Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional medical institutions.
If I were a Senator conducting a confirmation hearing for Dr. Marty Makary, the nominee to be the next commissioner of the Food and Drug
1d
Hosted on MSNMarty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDAMarty Makary, MD, MPH, rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV. Now the Johns Hopkins University surgeon and researcher has been nominated to lead the FDA.
Marty Makary, President Donald Trump’s pick to lead the US Food and Drug Administration, said he’s ready to carry out the mission of instituting “radical transparency” called for by Health and Human Services Secretary Robert F.
Marty Makary, President Trump’s pick to be FDA commissioner, promised to step down as an adviser to various health tech, medical device, and telehealth startups if confirmed.
Dr. Marty Makary, President Donald Trump’s pick to lead the FDA, will face the lawmakers standing between him and Senate confirmation on Thursday.
Donald Trump nominated Dr Marty Makary to lead the Food and Drug Administration, a man who shot to fame by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV.
If I were a Senator conducting a confirmation hearing for Dr. Marty Makary, the nominee to be the next commissioner of the Food and Drug
The Trump administration’s moves to shrink the federal workforce put the FDA’s ability to regulate drugs and oversee the pharmaceutical industry at risk, according to current and former agency employees.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results